396 related articles for article (PubMed ID: 24427158)
1. Dendritic cell-based immunotherapy for myeloid leukemias.
Schürch CM; Riether C; Ochsenbein AF
Front Immunol; 2013 Dec; 4():496. PubMed ID: 24427158
[TBL] [Abstract][Full Text] [Related]
2. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ.
Schürch C; Riether C; Amrein MA; Ochsenbein AF
J Exp Med; 2013 Mar; 210(3):605-21. PubMed ID: 23401488
[TBL] [Abstract][Full Text] [Related]
4. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection.
Srinivasan Rajsri K; Roy N; Chakraborty S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345204
[TBL] [Abstract][Full Text] [Related]
5. Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells.
Zhang X; Su Y; Song H; Yu Z; Zhang B; Chen H
Leuk Res; 2014 Jun; 38(6):673-81. PubMed ID: 24713261
[TBL] [Abstract][Full Text] [Related]
6. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
7. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients.
Fujii S; Fujimoto K; Shimizu K; Ezaki T; Kawano F; Takatsuki K; Kawakita M; Matsuno K
Cancer Res; 1999 May; 59(9):2150-8. PubMed ID: 10232602
[TBL] [Abstract][Full Text] [Related]
8. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation.
Mu H; Zhu X; Jia H; Zhou L; Liu H
Front Oncol; 2021; 11():643382. PubMed ID: 34055612
[TBL] [Abstract][Full Text] [Related]
11. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.
van den Ancker W; van Luijn MM; Westers TM; Bontkes HJ; Ruben JM; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Immunotherapy; 2010 Jan; 2(1):69-83. PubMed ID: 20635890
[TBL] [Abstract][Full Text] [Related]
13. [In vitro anti-leukemia activity of cord blood original cytotoxic T lymphocytes].
Zeng LJ; Tan H
Ai Zheng; 2005 Apr; 24(4):419-24. PubMed ID: 15820063
[TBL] [Abstract][Full Text] [Related]
14. Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells.
Hinterbrandner M; Rubino V; Stoll C; Forster S; Schnüriger N; Radpour R; Baerlocher GM; Ochsenbein AF; Riether C
JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34727093
[TBL] [Abstract][Full Text] [Related]
15. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia.
Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA
Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269
[TBL] [Abstract][Full Text] [Related]
17. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
18. Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation.
Chomel JC; Bonnet ML; Sorel N; Sloma I; Bennaceur-Griscelli A; Rea D; Legros L; Marfaing-Koka A; Bourhis JH; Ame S; Guerci-Bresler A; Rousselot P; Turhan AG
Oncotarget; 2016 Jun; 7(23):35293-301. PubMed ID: 27167108
[TBL] [Abstract][Full Text] [Related]
19. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
